Oral bisphosphonates—Drug holidays and discontinuing therapy
Author:
Publisher
Elsevier
Reference9 articles.
1. Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment;Cosman;J Clin Endocrinol Metab,2014
2. Effects of continuing or stopping alendronate after 5 years of treatment. The fracture intervention trial long-term extension;Black;JAMA,2006
3. Bisophosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk;Mignot;Osteoporos Int,2017
4. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with anti-resorptive agents;Hochberg;J Clin Endocrinol Metab,2002
5. Antifracture efficacy of anti-resorptive agents are related to changes in bone density;Wasnich;J Clin Endocrinol Metab,2000
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3